Stock Price & Analysis

Based on the analysis of Solventum Corp (SOLV.N), the stock presents a neutral outlook with potential upside driven by strategic initiatives and debt reduction, but tempered by mixed earnings expectations. Hold the stock as positive catalysts like the upcoming investor day and debt paydown may drive future growth, while being cautious of lower-than-expected free cash flow projections.

The price prediction for SOLV stock in 2025 is $78 per share. This forecast is supported by Mizuho's recent price target increase to $82, driven by potential debt paydown and improved margin outlook. However, the stock's current price of $75.15 and Fibonacci resistance levels suggest a more moderate upside to $78 by year-end.

The S1 support level for SOLV Stock is $72.99 ,The R1 resistant level for SOLV Stock is $79.07.

As of the end of day on 2025-03-19, the price of SOLV Stock was $76.59.

The target price for SOLV Stock according to analyst rating is 82.33, with the highest price target at 88.00 and the lowest at 75.00. Analysts have a Hold rating on SOLV Stock overall.

The market cap of SOLV is $13.0B.

SOLV may be overvalued due to mixed earnings and lower cash flow projections. Despite beating Q4 EPS estimates, FY25 guidance fell short, and free cash flow expectations were below consensus. Technical indicators show bearish signals, and the stock's price drop post-earnings suggests investor concern. While price targets have increased, the fundamentals don't fully support the current valuation.

Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.

The price prediction for SOLV stock by 2030 is approximately $100 per share. This forecast is based on the company's strategic sale of its Purification & Filtration business, which is expected to strengthen its balance sheet and focus on core growth areas. Analysts have raised their price targets, with some expecting up to $85 in the near term, suggesting potential for further growth by 2030.

SOLV has a total of 22007 employees.